View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Carole Braudeau
  • Carole Braudeau

Credit Morning 12/17/2025

Fresh speculation about Rexel's capital (La Lettre)|Grifols : S&P upgrades the corporate rating to BB-/stable from B+/stable|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 17/12/2025

Nouvelles rumeurs spéculatives sur le capital de Rexel (La Lettre)|S&P relève le rating corporate de Grifols de B+ à BB-/stable|

Dominic Rose ... (+2)
  • Dominic Rose
  • Naresh Chouhan

Thematic - 2026 Outlook - "5 More Years" (55pgs)

For access to the full note, please contact Naresh Chouhan ( ) With EU Pharma (ex-Novo) now having reached decade high valuations vs EuroStoxx600, we believe the sector has broken out & the sustainability of the growth profile will now generate continued strong performance. Consensus 5yr sales & EPS CAGR’s stand at 4% & 7% for 15x 2026 PE. We show there is upside to this from underestimated pipelines where cons. rarely fully models “monster” drugs & from M&A which we expect to be strong at JPM ...

GSK: 1 director

A director at GSK sold 6,000 shares at 1,829p and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close p...

Carole Braudeau
  • Carole Braudeau

Credit Morning 11/13/2025

Carrefour: Saadé family acquires stake, Peninsula exits|Emeria: an equity fundraising to enable bond refinancing?|Advanz Q3 25 results: Adj. EBITDA drops yoy and net leverage increases further – but not surprising|grenke Q3 25 results: Good operational performance YTD, but loss rate and NPLs increase|Finnair: no surprises on the FY 2026-2029 targets at first sight|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 13/11/2025

Carrefour : entrée de la famille Saadé au capital et sortie de Peninsula|Emeria : une levée d’equity pour permettre le refinancement des obligations ?|Advanz Q3 25 results: Adj. EBITDA drops yoy and net leverage increases further – but not surprising|grenke Q3 25 results: Good operational performance YTD, but loss rate and NPLs increase|Finnair: no surprises on the FY 2026-2029 targets at first sight|

Carole Braudeau
  • Carole Braudeau

Credit Morning 11/05/2025

Altice France has reportedly launched the sale of Netco (L’Informé)|Ban on thermal vehicles in Europe after 2035: the debate is reignited|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 05/11/2025

Altice France aurait lancé la vente de Netco (L’Informé)|Interdiction du thermique en Europe après 2035 : le débat est relancé|

Jamila El Bougrini ... (+2)
  • Jamila El Bougrini
  • Thibaut Voglimacci-Stephanopoli
Carole Braudeau
  • Carole Braudeau

Credit Morning 10/22/2025

Playtech falls after being identified as the author of a report against Evolution|Verisure: a new recapitalisation dividend for Hellman|Worldline: revenue decline slows in Q3. FY25 guidance is slightly revised downwards.|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 22/10/2025

Playtech chute après avoir été identifié comme l’auteur d’un rapport contre Evolution|Verisure : un nouveau dividende récap pour Hellman|Worldline : la baisse du CA ralentit au T3. La guidance 2025 est légèrement affinée à la baisse|

Dominic Rose ... (+2)
  • Dominic Rose
  • Naresh Chouhan

GSK- A New Dawn – Double Upgrade (BUY, TP £17, 33pgs)

For access to the full note, please contact Naresh Chouhan ( )

Dominic Rose ... (+2)
  • Dominic Rose
  • Naresh Chouhan

GSK & Sanofi - Time To Divest Vaccines? (23pgs)

For access to the full note, please contact Naresh Chouhan ( )

Carole Braudeau
  • Carole Braudeau
AXA AXA
CEC CECONOMY AG ... (+13)

Credit Morning 08/01/2025

S&P lowers outlook to negative vs. stable on ELO's 'BB-' rating|ZF H1 25 results: Better than one could have feared… but some water into the wine|Emeria announces the sale of Assurimo|Viridien: Profitability improvement, good FCF generation, and guidance confirmed|

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch